Recruiting Clinical Trials

Displaying 121 - 130 of 242 result(s)
Study Title Condition Phase Location
A Phase IIIb Study of the Safety and Efficacy of Tisagenlecleucel Out of Specification for Commercial Release in Patients Who Are Consistent With the Label Indication B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma Phase 3
  • Country: 
    Japan
EPIK-P2: A Phase II Double-blind Study With an Upfront, 16-week Randomized, Placebo-controlled Period, to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum ( ... PIK3CA-related Overgrowth Spectrum (PROS) Phase 2
  • Country: 
    United States
  • Country: 
    Canada
  • Country: 
    China
  • Country: 
A Phase 1, Open-label, Single-dose, Multi-center, Parallel Group Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Mild, Moderate or Severe Hepatic Impairment Compared to Matched Healthy Control Participants. Small Cell Lung Carcinoma Phase 1
  • Country: 
    United States
A Multicenter, Single-arm, Open-label Trial to Evaluate Efficacy and Safety of Oral, Twice Daily Iptacopan in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy Paroxysmal Nocturnal Hemoglobinuria (PNH) Phase 3
  • Country: 
    China
  • Country: 
    Czech Republic
  • Country: 
    France
  • Country: 
A Phase IIIb, Open-label, Single-arm, Single-dose, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of Gene Replacement Therapy With Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA) Spinal Muscular Atrophy Phase 3
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Belgium
  • Country: 
A 12-month, Prospective, Multi-center Post-authorization Commitment (PAC) Study Monitoring Safety in Adult Patients With Relapsing-remitting Multiple Sclerosis Newly Initiated on Gilenya (Fingolimod) in Taiwan (SPRING) Multiple Sclerosis Phase 4
  • Country: 
    Taiwan
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase III Study to Evaluate the Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients IgA Nephropathy Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
A Phase III, Randomized, Controlled, Open-label, Multicenter, Global Study of Capmatinib Versus SoC Docetaxel Chemotherapy in Previously Treated Patients With EGFR wt, ALK Negative, Locally Advanced or Metastatic (Stage IIIB/IIIC or IV) NSCLC Harbori ... Carcinoma, Non-Small-Cell Lung Phase 3
  • Country: 
    Belgium
  • Country: 
    Brazil
  • Country: 
    Bulgaria
  • Country: 
A Multicenter Study to Evaluate Long-term Safety and Tolerability of Open Label Sacubitril/Valsartan in Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed Study CLCZ696B2319 Heart Failure Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Austria
  • Country: 
A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography (OCT) Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti- VEGF Injections Neovascular Age-Related Macular Degeneration Not Given
  • Country: 
    Canada
  • Country: 
    Germany
  • Country: 
    Ireland
  • Country: